Aeglea Bio Therapeutics Inc AGLE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:05 PM EDT
0.4312quote price arrow down-0.0102 (-2.3108%)
Volume
106,389
52 week range
0.37 - 8.50
Loading...
  • Open0.43
  • Day High0.45
  • Day Low0.4283
  • Prev Close0.4414
  • 52 Week High8.50
  • 52 Week High Date10/15/21
  • 52 Week Low0.37
  • 52 Week Low Date08/02/22

Key Stats

  • Market Cap26.38M
  • Shares Out61.17M
  • 10 Day Average Volume0.27M
  • Dividend-
  • Dividend Yield-
  • Beta1.65
  • YTD % Change-90.95

KEY STATS

  • Open0.43
  • Day High0.45
  • Day Low0.4283
  • Prev Close0.4414
  • 52 Week High8.50
  • 52 Week High Date10/15/21
  • 52 Week Low0.37
  • 52 Week Low Date08/02/22
  • Market Cap26.38M
  • Shares Out61.17M
  • 10 Day Average Volume0.27M
  • Dividend-
  • Dividend Yield-
  • Beta1.65
  • YTD % Change-90.95

RATIOS/PROFITABILITY

  • EPS (TTM)-1.26
  • P/E (TTM)-0.34
  • Fwd P/E (NTM)-0.43
  • EBITDA (TTM)-85.995M
  • ROE (TTM)-86.14%
  • Revenue (TTM)7.03M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-1,244.84%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aeglea Bio Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology company. It is focused on human enzyme therapeutics to treat people with rare metabolic diseases. Its lead product candidate is pegzilarginase, which is a recombinant human arginase 1 that enzymatically degrades the amino acid arginine to lower arginine levels in patients with Arginase 1 Deficiency. It has engineered pegzilarginase with modifications that enhance the stability and arginine-degrading activity of...
Russell Cox
Independent Chairman of the board
Jim Kastenmayer J.D., Ph.D.
Interim President & Chief Executive Officer
Leslie Sloan Ph.D.
Chief Operating Officer
Jonathan Alspaugh
Chief Financial Officer
Address
805 Las Cimas Parkway, Suite 100
Austin, TX
78746
United States

Top Peers

SYMBOLLASTCHG%CHG
ARAV
Aravive Inc
0.9825+0.0673+7.35%
UBX
UNITY Biotechnology Inc
0.398-0.007-1.7284%
ATHX
Athersys Inc
1.40-0.23-14.10%
ERYP
Erytech Pharma SA
0.62+0.019+3.16%
MRKR
Marker Therapeutics Inc
0.3304-0.0147-4.2596%